Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy
出版年份 2016 全文链接
标题
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy
作者
关键词
-
出版物
CANCER
Volume 122, Issue 15, Pages 2418-2425
出版商
Wiley
发表日期
2016-05-13
DOI
10.1002/cncr.30054
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 1481PDAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH A MODERATELY EMETOGENIC CHEMOTHERAPY: A MULTICENTER, PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED STUDY IN JAPANESE GYNECOLOGIC PATIENTS RECEIVING PACLITAXEL AND CARBOPLATIN
- (2017) H. Yahata et al. ANNALS OF ONCOLOGY
- A prospective study on the incidence of delayed nausea and vomiting following administration of carboplatin containing regimens for treatment of cancer without prophylactic aprepitant
- (2017) M. A. Waqar et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial
- (2015) C. Weinstein et al. ANNALS OF ONCOLOGY
- Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review
- (2015) K. Jordan et al. ANNALS OF ONCOLOGY
- Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial
- (2015) Lee S Schwartzberg et al. LANCET ONCOLOGY
- Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials
- (2015) Bernardo L Rapoport et al. LANCET ONCOLOGY
- Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer
- (2015) Hideki Kusagaya et al. LUNG CANCER
- Aprepitant in patients with advanced non-small-cell lung cancer receiving carboplatin-based chemotherapy
- (2014) Yasuhiro Ito et al. LUNG CANCER
- A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy
- (2013) M Tanioka et al. BRITISH JOURNAL OF CANCER
- Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2011) Ethan Basch et al. JOURNAL OF CLINICAL ONCOLOGY
- Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference
- (2010) F. Roila et al. ANNALS OF ONCOLOGY
- Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study
- (2009) Bernardo L. Rapoport et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-Induced Nausea and Vomiting
- (2008) Paul J. Hesketh NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search